Biotech Acquisition Co Contracts & Agreements
34 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (2)
- Mergers & Acquisitions (3)
- Real Estate (3)
- Uncategorized (8)
- Promissory Note of the Company to Biotech Sponsor LLC dated October 4, 2022 (Filed With SEC on October 11, 2022)
- Promissory Note of the Company to Cryfield Investments, Ltd. dated October 4, 2022 (Filed With SEC on October 11, 2022)
- Termination and Release Agreement, dated as of June 10, 2022, by and among Biotech Acquisition Company, Blade Merger Subsidiary, Inc., Blade Therapeutics, Inc., Biotech Sponsor... (Filed With SEC on June 13, 2022)
- Amendment to Agreement and Plan of Merger, dated May 17, 2022, between Biotech Acquisition Company, Blade Merger Subsidiary, Inc., Blade Therapeutics, Inc., Biotech Sponsor LLC,... (Filed With SEC on May 23, 2022)
- Britannia Life Science Center Lease, dated as of April 28, 2016, by and among Blade Therapeutics, Inc. and Bayside Acquisition, LLC (Filed With SEC on March 15, 2022)
- First Amendment to Lease, dated as of October 15, 2021, by and among Blade Therapeutics, Inc. and Bayside Acquisition, LLC (Filed With SEC on March 15, 2022)
- Sublease Agreement, dated as of October 1, 2019, by and among Blade Therapeutics, Inc. and Molecular Transport Inc (Filed With SEC on March 15, 2022)
- Agreement and Plan of Merger, dated as of November 8, 2021, by and among Biotech Acquisition Company, Blade Merger Subsidiary, Inc., Blade Therapeutics, Inc., Biotech Sponsor LLC,... (Filed With SEC on November 8, 2021)
- Form of Voting Agreement, dated as of November 8, 2021, by and among Biotech Acquisition Company, Blade Therapeutics, Inc., and the stockholders of Blade Therapeutics, Inc. party... (Filed With SEC on November 8, 2021)
- Form of Lock-Up Agreement, dated as of November 8, 2021, by and between Biotech Acquisition Company and the stockholders of Blade Therapeutics, Inc. party thereto (Filed With SEC on November 8, 2021)
- Sponsor Agreement, dated as of November 8, 2021, by and between Biotech Acquisition Company, Blade Therapeutics, Inc., and Biotech Sponsor LLC (Filed With SEC on November 8, 2021)
- Form of Subscription Agreement, dated as of November 8, 2021, by and among Biotech Acquisition Company, and the subscriber parties thereto (Filed With SEC on November 8, 2021)
- Form of Amended and Restated Registration Rights Agreement, dated as of November 8, 2021, by and among Biotech Acquisition Company, Biotech Sponsor LLC, and certain equityholders... (Filed With SEC on November 8, 2021)
- Description of Registered Securities (Filed With SEC on March 23, 2021)
- Underwriting Agreement, dated January 25, 2021 by and between the Company and Cantor Fitzgerald & Co., as representatives of the several underwriters (Filed With SEC on January 29, 2021)
- Warrant Agreement, dated January 25, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (Filed With SEC on January 29, 2021)
- Letter Agreement, dated January 25, 2021, by and among the Company, its officers, its directors and the Sponsor (Filed With SEC on January 29, 2021)
- Investment Management Trust Agreement, dated January 25, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on January 29, 2021)
- Registration Rights Agreement, dated January 25, 2021, by and between the Company and the Sponsor (Filed With SEC on January 29, 2021)
- Administrative Support Agreement, dated January 25, 2021, by and between the Company and the Sponsor (Filed With SEC on January 29, 2021)
- Sponsor Warrants Purchase Agreement, dated January 25, 2021 by and between the Company and the Sponsor (Filed With SEC on January 29, 2021)
- Form of Underwriting Agreement (Filed With SEC on January 12, 2021)
- Specimen Unit Certificate (Filed With SEC on January 12, 2021)
- Specimen Class A Ordinary Share Certificate (Filed With SEC on January 12, 2021)
- Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on January 12, 2021)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 12, 2021)
- Promissory Note, dated September 8, 2020, issued to Biotech Sponsor LLC (Filed With SEC on January 12, 2021)
- Form of Letter Agreement among the Registrant and its directors and officers and Biotech Sponsor LLC (Filed With SEC on January 12, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 12, 2021)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on January 12, 2021)
- Securities Subscription Agreement, dated September 8, 2020, between the Registrant and Biotech Sponsor LLC (Filed With SEC on January 12, 2021)
- Form of Sponsor Warrants Purchase Agreement between the Registrant and Biotech Sponsor LLC (Filed With SEC on January 12, 2021)
- Form of Indemnity Agreement (Filed With SEC on January 12, 2021)
- Form of Administrative Services Agreement, by and between the Registrant and an affiliate of the Registrant (Filed With SEC on January 12, 2021)
